Cross section calculations of medical Pd-103 radioisotope using a and He-3 induced reactions

Abstract

One of the most popular radioisotopes used in the prostate brachytherapy is Palladium-103 ((103)p a) The radioactive plaque is sewn onto the eye as to cover the intraocular tumor shadow with a 2-3 mm margin. These plaques are temporary and radiation is continuously delivered over 5 to 7 days. At the end of treatment, the plaque is removed from eye. In this study, production cross section calculations of, Pd-103 radionuclide used in brachytherapy produced by Ru-101(alpha,2n) and Ru-100(alpha, n), Ru-102(He-3,2n) and Ru-101(He-3, n) reactions have been investigated in the different incident energy range up to 35 MeV. Two component Exciton model and Generalized Superfluid model of the TALYS 1.6 code used to perform calculations and calculation results were compared with experimental results reported in the literature.